Karl-Heinz Pflüger

Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

Michael Lübbert, Stefan Suciu, Liliana Baila et al. · Journal of Clinical Oncology · 2011 · 551 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group

Michael Lübbert, Stefan Suciu, Anne Hagemeijer et al. · Annals of Hematology · 2015 · 87 citations · Full text

Medicine, Oncology, Pharmacology +15

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized german multicenter trial

K. Havemann, M. Wolf, Rolf Holle et al. · Cancer · 1987 · 65 citations · Full text

Medicine, Oncology, Chemotherapy +12

High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation

Christopher P. Fox, Ariane Boumendil, Norbert Schmitz et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 48 citations

Medicine, Hematology, Oncology +13

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin’s lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

Michael Pfreundschuh, C. Zwick, Samira Zeynalova et al. · Annals of Oncology · 2007 · 45 citations · Full text

Medicine, Hematology, Oncology +11